Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$47.75 - $66.88 $335,061 - $469,296
7,017 New
7,017 $341,000
Q2 2021

Aug 11, 2021

SELL
$49.67 - $68.96 $446,682 - $620,157
-8,993 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$60.06 - $89.52 $211,050 - $314,573
-3,514 Reduced 28.1%
8,993 $569,000
Q4 2020

Feb 12, 2021

BUY
$53.26 - $77.18 $42,181 - $61,126
792 Added 6.76%
12,507 $900,000
Q3 2020

Nov 04, 2020

SELL
$57.51 - $75.36 $655,901 - $859,480
-11,405 Reduced 49.33%
11,715 $883,000
Q2 2020

Jul 28, 2020

SELL
$32.91 - $59.82 $1.04 Million - $1.89 Million
-31,547 Reduced 57.71%
23,120 $1.38 Million
Q1 2020

Apr 21, 2020

SELL
$26.79 - $38.99 $35,845 - $52,168
-1,338 Reduced 2.39%
54,667 $1.91 Million
Q4 2019

Feb 12, 2020

SELL
$29.07 - $35.63 $33,924 - $41,580
-1,167 Reduced 2.04%
56,005 $1.63 Million
Q3 2019

Nov 07, 2019

SELL
$28.19 - $41.75 $679,660 - $1.01 Million
-24,110 Reduced 29.66%
57,172 $1.98 Million
Q2 2019

Aug 06, 2019

BUY
$19.91 - $28.97 $56,803 - $82,651
2,853 Added 3.64%
81,282 $2.32 Million
Q1 2019

May 06, 2019

BUY
$18.84 - $21.36 $77,112 - $87,426
4,093 Added 5.51%
78,429 $1.66 Million
Q4 2018

Feb 11, 2019

SELL
$17.56 - $21.2 $25,988 - $31,376
-1,480 Reduced 1.95%
74,336 $1.48 Million
Q3 2018

Nov 14, 2018

BUY
$17.1 - $23.55 $448,037 - $617,033
26,201 Added 52.81%
75,816 $1.53 Million
Q2 2018

Aug 14, 2018

BUY
$14.65 - $23.75 $91,811 - $148,841
6,267 Added 14.46%
49,615 $1.1 Million
Q1 2018

May 14, 2018

BUY
$14.4 - $16.8 $381,283 - $444,830
26,478 Added 156.95%
43,348 $639,000
Q4 2017

Feb 14, 2018

SELL
$15.3 - $17.4 $53,320 - $60,638
-3,485 Reduced 17.12%
16,870 $272,000
Q3 2017

Nov 13, 2017

SELL
$13.7 - $15.65 $1,397 - $1,596
-102 Reduced 0.5%
20,355 $316,000
Q2 2017

Aug 14, 2017

BUY
N/A
20,457
20,457 $253,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $582M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.